Department of Ophthalmology, Charing Cross and Hammersmith Hospitals, London, UK.
Eye (Lond). 2011 Sep;25(9):1219-24. doi: 10.1038/eye.2011.77. Epub 2011 Jul 22.
A literature review revealed there is no outcome data for endoscopic endonasal dacryocystorhinostomy (EES-DCR) in the subgroup of patients with acquired partial nasolacrimal duct obstruction (NDO). This study aimed to compare the results of EES-DCR vs external DCR (ext-DCR) in the treatment of partial NDO.
This study is designed as a prospective nonrandomised comparative clinical trial.
In total, 46 adult patients with acquired partial NDO participated in this study.
Partial (sometimes called 'functional') NDO (epiphora in the presence of patent syringing) was confirmed by nuclear lacrimal scintigraphy or delayed drainage on dacryocystography. Patients with 'functional' epiphora from other causes were excluded. Post-operative outcome was assessed at 6 months. Overall, 21 (46%) patients had EES-DCR and 25 patients had (54%) ext-DCR.
Subjective success was based on patient symptoms, objective success on patency with syringing and a functioning rhinostomy evaluated using the functional endoscopic dye test (FEDT).
In total 18 out of 21 (86%) of EES-DCR patients had marked reduction (n=11) or complete resolution (n=7) and 25 out of 25 (100%) of ext-DCR had marked reduction (n=9) or complete resolution (n=16) of epiphora. In total 17 out of 18 (94%) of the EES-DCR patients with subjective success had a positive FEDT. All 25 out of 25 (100%) ext-DCR patients with subjective success had a positive FEDT. The three failed EES-DCR patients were all blocked on syringing. Statistically, EES-DCR does not achieve the same success rate as ext-DCR in this study (P=0.09, two-tailed Fisher's exact test, 0.045 one-tailed).
Both endoscopic and external DCRs provide satisfactory outcomes in acquired partial NDO. The success rate is nevertheless higher in ext-DCR compared with EES-DCR.
文献回顾显示,对于获得性部分鼻泪管阻塞(NDO)亚组患者,内镜鼻内泪囊鼻腔造口术(EES-DCR)没有结果数据。本研究旨在比较 EES-DCR 与外部 DCR(ext-DCR)治疗部分 NDO 的结果。
本研究设计为前瞻性非随机对照临床试验。
共有 46 名患有获得性部分 NDO 的成年患者参与了这项研究。
通过核泪液闪烁显像或泪道造影延迟引流确认部分(有时称为“功能性”)NDO(冲洗时有溢泪)。排除因其他原因出现“功能性”溢泪的患者。术后 6 个月评估术后结果。共有 21 名(46%)患者接受 EES-DCR,25 名(54%)患者接受 ext-DCR。
主观疗效基于患者症状,客观疗效基于冲洗通畅性和使用功能性内镜染料测试(FEDT)评估的鼻造口功能。
EES-DCR 患者中,21 例(86%)患者溢泪明显减少(n=11)或完全缓解(n=7),25 例(100%)ext-DCR 患者溢泪明显减少(n=9)或完全缓解(n=16)。EES-DCR 中,18 例(94%)主观疗效良好的患者中,17 例(94%)FEDT 阳性。25 例(100%)ext-DCR 主观疗效良好的患者中,25 例(100%)FEDT 阳性。3 例 EES-DCR 失败的患者均因冲洗受阻。统计学上,EES-DCR 在本研究中未达到与 ext-DCR 相同的成功率(P=0.09,双侧 Fisher 精确检验,0.045 单侧)。
内镜和外部 DCR 均可为获得性部分 NDO 提供满意的结果。然而,ext-DCR 的成功率高于 EES-DCR。